Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

ARCA Biopharma Completes Enrollment in Phase 2b ASPEN-COVID-19 Clinical Trial Evaluating rNAPc2 as Treatment for Patients Hospitalized with COVID-19

AmericanPharmaceuticalReviewDecember 03, 2021

Tag: ARCA , rNAPc2 , COVID-19

PharmaSources Customer Service